Skip to content

Author

Fabrizio Calapai

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comparative Adverse Event Reporting Patterns of Amoxicillin and Amoxicillin/Clavulanic Acid in FAERS: A 2022–2025 Disproportionality Analysis

Amoxicillin, alone or combined with clavulanic acid, is widely used for the treatment of bacterial infections. While clavulanic acid expands amoxicillin's antibacterial spectrum by inhibiting β‐lactamases, differences in their real‐world safety profiles and reporting patterns remain relevant for pharmacovigilance and a...

P. Irrera, Ilaria Ammendolia, Gabriella Frattima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.